Snowball logo
logo
0822_logo

GemVax&KAEL Co.Ltd

082270 β€’ KQ
β‚©12,030.00β‚©0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
60,370.675,804.172,208.662,691.781,530.887,414.8
COGS
41,489.853,942.946,160.242,976.646,605.151,528.8
Gross Profit
18,880.821,861.226,048.319,715.134,925.835,885.9
Operating Expenses & Income
Operating Income
(2,479.1)321.5(13,569)(38,681.7)3,565.55,745
Total Operating Expenses
62,820.779,376.880,076.8126,330.177,965.381,669.8
R&D Expenses
7,241.111,63415,670.235,064.314,631.211,766.2
Selling General & Admin Expenses
14,003.712,973.716,84521,445.35,266.36,379.9
Earnings from Continuing Operations
Interest Expense
(405)(445.3)(462.9)(3,161.2)(6,646.9)(6,382.6)
Interest Income
13,172.919,268.713,436.823,544.2212.8214.5
Income Tax Expense
------
Net Income
Net Income
12,057.9(19,603.8)(27,176.6)(87,218.7)(11,336.6)(3,944.6)
Supplemental
EBIT
(2,450.1)-----
EBITDA
------
In millions of KRW, except % and values per 1 share